CJC-1295 (WITH DAC) 5 mg
Description
CJC-1295 (with DAC) — Research Grade Peptide
Overview
CJC-1295 (with DAC) is a research-grade synthetic growth-hormone-releasing hormone (GHRH) analog modified with Drug Affinity Complex (DAC) for extended in vitro stability and sustained activity modeling. Supplied as a lyophilized peptide for stability and analytical precision; QC-verified for sequence fidelity and batch purity..
Research context
Intended for non-clinical studies, CJC-1295 (with DAC) is used to probe GHRH receptor binding, prolonged downstream cAMP/PKA signaling, somatotroph activity models, and mechanistic combination studies with other endocrine or metabolic agents.
Product Information
- Product name CJC-1295 with DAC
- FormulaC165H269N47O46
- Molecular weight~3647.20 g/mol
- CAS number446262-90-4
- AppearanceWhite to off-white lyophilized powder
- FormLyophilized solid
- Purity>99% (HPLC verified)
Storage & Handling
- Store at −20 °C; protect from moisture and light.
- Lyophilized for stability; avoid repeated freeze–thaw cycles after reconstitution.
- Follow institutional protocols for reconstitution and aseptic handling.
Research Applications
- In vitro GHRH receptor binding and signaling assays
- Prolonged cAMP/PKA pathway and somatotroph activity studies
- Cellular secretion assays and GH-axis modeling
- Mechanistic combination studies with other endocrine/metabolic agents
Legal & Safety
For laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or veterinary use. No therapeutic, diagnostic, or dosing claims are made. This product has not been evaluated by the U.S. Food and Drug Administration (FDA) and is not intended to diagnose, treat, cure, or prevent any disease.
